Pathogenesis of COPD

John R. Spurzem, Stephen I. Rennard

Research output: Contribution to journalReview article

117 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized and defined by limitation of expiratory airflow. This can result from several types of anatomical lesions, including loss of lung elastic recoil and fibrosis and narrowing of small airways. Inflammation, edema, and secretions also contribute variably to airflow limitation. Smoking can cause COPD through several mechanisms. First, smoke is a powerful inducer of an inflammatory response. Inflammatory mediators, including oxidants and proteases, are believed to play a major role in causing lung damage. Smoke can also alter lung repair responses in several ways. Inhibition of repair may lead to tissue destruction that characterizes emphysema, whereas abnormal repair can lead to the peribronchiolar fibrosis that causes airflow limitation in small airways. Genetic factors likely play a major role and probably account for much of the heterogeneity susceptibility to smoke and other factors. Many factors may play a role, but to date, only α-1 protease inhibitor deficiency has been unambiguously identified. Exposures other than cigarette smoke can contribute to the development of COPD. Inflammation of the lower respiratory tract that results from asthma or other chronic disorders may also contribute to the development of fixed airway obstruction. COPD is not only a disease of the lungs but is also a systemic inflammatory disorder. Muscular weakness, increased risk for atherosclerotic vascular disease, depression, osteoporosis, and abnormalities in fluids and electrolyte balance may all be consequences of COPD. Advances in understanding the pathogenesis of COPD have the potential for identifying new therapeutic targets that could alter the natural history of this devastating disorder.

Original languageEnglish (US)
Pages (from-to)142-153
Number of pages12
JournalSeminars in Respiratory and Critical Care Medicine
Volume26
Issue number2
DOIs
StatePublished - Apr 1 2005

Fingerprint

Chronic Obstructive Pulmonary Disease
Smoke
Water-Electrolyte Balance
Lung
Fibrosis
Inflammation
Pulmonary Ventilation
Muscle Weakness
Emphysema
Airway Obstruction
Protease Inhibitors
Natural History
Vascular Diseases
Oxidants
Tobacco Products
Respiratory System
Lung Diseases
Osteoporosis
Edema
Peptide Hydrolases

Keywords

  • Antioxidant
  • Bronchitis
  • Cigarette smoking
  • Emphysema
  • Peribronchiolar fibrosis
  • Protease
  • Repair

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Pathogenesis of COPD. / Spurzem, John R.; Rennard, Stephen I.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 26, No. 2, 01.04.2005, p. 142-153.

Research output: Contribution to journalReview article

Spurzem, John R. ; Rennard, Stephen I. / Pathogenesis of COPD. In: Seminars in Respiratory and Critical Care Medicine. 2005 ; Vol. 26, No. 2. pp. 142-153.
@article{0d1c3ad7984440fcae5c3b3222ee9421,
title = "Pathogenesis of COPD",
abstract = "Chronic obstructive pulmonary disease (COPD) is characterized and defined by limitation of expiratory airflow. This can result from several types of anatomical lesions, including loss of lung elastic recoil and fibrosis and narrowing of small airways. Inflammation, edema, and secretions also contribute variably to airflow limitation. Smoking can cause COPD through several mechanisms. First, smoke is a powerful inducer of an inflammatory response. Inflammatory mediators, including oxidants and proteases, are believed to play a major role in causing lung damage. Smoke can also alter lung repair responses in several ways. Inhibition of repair may lead to tissue destruction that characterizes emphysema, whereas abnormal repair can lead to the peribronchiolar fibrosis that causes airflow limitation in small airways. Genetic factors likely play a major role and probably account for much of the heterogeneity susceptibility to smoke and other factors. Many factors may play a role, but to date, only α-1 protease inhibitor deficiency has been unambiguously identified. Exposures other than cigarette smoke can contribute to the development of COPD. Inflammation of the lower respiratory tract that results from asthma or other chronic disorders may also contribute to the development of fixed airway obstruction. COPD is not only a disease of the lungs but is also a systemic inflammatory disorder. Muscular weakness, increased risk for atherosclerotic vascular disease, depression, osteoporosis, and abnormalities in fluids and electrolyte balance may all be consequences of COPD. Advances in understanding the pathogenesis of COPD have the potential for identifying new therapeutic targets that could alter the natural history of this devastating disorder.",
keywords = "Antioxidant, Bronchitis, Cigarette smoking, Emphysema, Peribronchiolar fibrosis, Protease, Repair",
author = "Spurzem, {John R.} and Rennard, {Stephen I.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1055/s-2005-869535",
language = "English (US)",
volume = "26",
pages = "142--153",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Pathogenesis of COPD

AU - Spurzem, John R.

AU - Rennard, Stephen I.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Chronic obstructive pulmonary disease (COPD) is characterized and defined by limitation of expiratory airflow. This can result from several types of anatomical lesions, including loss of lung elastic recoil and fibrosis and narrowing of small airways. Inflammation, edema, and secretions also contribute variably to airflow limitation. Smoking can cause COPD through several mechanisms. First, smoke is a powerful inducer of an inflammatory response. Inflammatory mediators, including oxidants and proteases, are believed to play a major role in causing lung damage. Smoke can also alter lung repair responses in several ways. Inhibition of repair may lead to tissue destruction that characterizes emphysema, whereas abnormal repair can lead to the peribronchiolar fibrosis that causes airflow limitation in small airways. Genetic factors likely play a major role and probably account for much of the heterogeneity susceptibility to smoke and other factors. Many factors may play a role, but to date, only α-1 protease inhibitor deficiency has been unambiguously identified. Exposures other than cigarette smoke can contribute to the development of COPD. Inflammation of the lower respiratory tract that results from asthma or other chronic disorders may also contribute to the development of fixed airway obstruction. COPD is not only a disease of the lungs but is also a systemic inflammatory disorder. Muscular weakness, increased risk for atherosclerotic vascular disease, depression, osteoporosis, and abnormalities in fluids and electrolyte balance may all be consequences of COPD. Advances in understanding the pathogenesis of COPD have the potential for identifying new therapeutic targets that could alter the natural history of this devastating disorder.

AB - Chronic obstructive pulmonary disease (COPD) is characterized and defined by limitation of expiratory airflow. This can result from several types of anatomical lesions, including loss of lung elastic recoil and fibrosis and narrowing of small airways. Inflammation, edema, and secretions also contribute variably to airflow limitation. Smoking can cause COPD through several mechanisms. First, smoke is a powerful inducer of an inflammatory response. Inflammatory mediators, including oxidants and proteases, are believed to play a major role in causing lung damage. Smoke can also alter lung repair responses in several ways. Inhibition of repair may lead to tissue destruction that characterizes emphysema, whereas abnormal repair can lead to the peribronchiolar fibrosis that causes airflow limitation in small airways. Genetic factors likely play a major role and probably account for much of the heterogeneity susceptibility to smoke and other factors. Many factors may play a role, but to date, only α-1 protease inhibitor deficiency has been unambiguously identified. Exposures other than cigarette smoke can contribute to the development of COPD. Inflammation of the lower respiratory tract that results from asthma or other chronic disorders may also contribute to the development of fixed airway obstruction. COPD is not only a disease of the lungs but is also a systemic inflammatory disorder. Muscular weakness, increased risk for atherosclerotic vascular disease, depression, osteoporosis, and abnormalities in fluids and electrolyte balance may all be consequences of COPD. Advances in understanding the pathogenesis of COPD have the potential for identifying new therapeutic targets that could alter the natural history of this devastating disorder.

KW - Antioxidant

KW - Bronchitis

KW - Cigarette smoking

KW - Emphysema

KW - Peribronchiolar fibrosis

KW - Protease

KW - Repair

UR - http://www.scopus.com/inward/record.url?scp=18144408336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144408336&partnerID=8YFLogxK

U2 - 10.1055/s-2005-869535

DO - 10.1055/s-2005-869535

M3 - Review article

C2 - 16088433

AN - SCOPUS:18144408336

VL - 26

SP - 142

EP - 153

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 2

ER -